Press releases
-
5 July 2010 - Paris (France)21th Neuronal Plasticity Prize awarded to three eminent scientists for their research into the domain of the Neuroendocrine Control of Behavior: Thomas R. Insel, Bruce McEwen and Donald Pfaff
-
26 June 2010 - Paris (France)Ipsen’s partner Roche confirms the promising efficacy profile of Taspoglutide
-
22 June 2010 - Paris (France)Encouraging results of GuidAge®, large scale European trial conducted in the prevention of Alzheimer’s Dementia
-
18 June 2010 - Paris (France)Ipsen’s partner Roche announces amendment of the trial protocols for the taspoglutide phase III programme
-
17 June 2010 - Paris (France) and Laguna Niguel (CA, USA)OBI-1 developed by Ipsen and Inspiration has obtained a positive opinion for the orphan drug status in Europe
-
9 June 2010 - Paris (France)Implementation of a Sponsored Level I American Depositary Receipt (ADR) program: A new step in Ipsen's development in the United States
-
28 May 2010 - Paris (France)Combined Shareholders’ Meeting of Ipsen S.A. held on 28 May 2010
-
11 May 2010 - Paris (France)6th Colloque Médecine et Recherche of the Fondation Ipsen in the Cancer Science series: “Stem Cells and Cancer”
-
4 May 2010 - Paris (France)25th Colloque Médecine et Recherche of the Fondation Ipsen in the series Alzheimer Disease: “Two Faces of Evil: Cancer and Neurodegeneration”
-
4 May 2010 - Paris (France)18th Colloque Médecine et Recherche of the Fondation Ipsen in the Neurosciences series: “Characterizing Consciousness: From Cognition to the Clinic ? »”
2009 Ipsen Annual Report
CONTACT US
Didier Véron
Director, Public Affairs and Corporate Communications
Tel.: +33 (0)1 58 33 51 16
Fax: +33 (0)1 58 33 50 58
Send an e-mail
Pipeline
